Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis

BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor approved in Japan for the treatment of ulcerative colitis (UC). Differences in the safety profile of tofacitinib in Japanese patients versus the global population, such as a higher risk of herpes zoster, have been reported. OB...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflamm Intest Dis
Hauptverfasser: Suzuki, Yasuo, Watanabe, Mamoru, Matsui, Toshiyuki, Motoya, Satoshi, Hisamatsu, Tadakazu, Yuasa, Hirotoshi, Tabira, Junichi, Isogawa, Naoki, Tsuchiwata, Shinichi, Arai, Shoko, Hibi, Toshifumi
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873059/
https://ncbi.nlm.nih.gov/pubmed/31768386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502144
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge